WorldPharmaNews
  • Home
  • Business
  • Research
  • Events
  • Regulatory

Takeda

TakedaLocated in Osaka, Japan, Takeda is a research-based global company with its main focus on pharmaceuticals. As the largest pharmaceutical company in Japan and one of the global leaders of the industry, Takeda is committed to strive towards better health for patients worldwide through leading innovation in medicine. Additional information about Takeda is available through its corporate website, www.takeda.com.

Takeda RSS Channel

Filters
List of articles in category Takeda
Title Published Date
Takeda announces approval of Moderna's COVID-19 vaccine in Japan 21 May 2021
Takeda expands COVID-19 vaccine supply in Japan through partnership with Moderna and Government of Japan 29 October 2020
Takeda to invest more than 100 million Euros in dengue vaccine manufacturing plant in Germany 01 December 2016
Takeda announces sale of respiratory portfolio to AstraZeneca 16 December 2015
Takeda establishes new trading company and reinforces business structure in China 22 January 2013
Takeda's exclusive distribution of Pfizer products in Japan 18 June 2012
Takeda to Acquire URL Pharma 12 April 2012
Open-source drug research consortium draws a major new champion 05 April 2012
New Structure of Business Operations for a Global Pharmaceutical Company 06 November 2011
Takeda completes acquisition and names new CEO of Nycomed 30 September 2011
Takeda to Acquire Nycomed - Transaction will Transform Takeda's Global Business 19 May 2011
Takeda to Establish Four Sales and Marketing Subsidiaries 05 October 2009
Takeda to Revise Timing of Alogliptin and Alogliptin/ACTOS MAA Filing in Europe 11 June 2009
Takeda to Sponsor Berlin Marathon 2007 29 September 2007
Lundbeck and Takeda form Alliance to Develop and Commercialize a Portfolio of Novel Compounds 18 September 2007
Takeda's Investigational Compound TAK-536 Enters into Phase 2 Clinical Stage in Japan 03 September 2007

Business & Industry

  • Pfizer to acquire Global Blood Therapeutics for $5.4 billion to enhance presence in rare hematology
  • Roche's subcutaneous formulation of Tecentriq demonstrates positive Phase III results
  • Bayer Consumer Health leaders propose new principles for science-led self-care
  • GSK signs agreement to support pandemic preparedness in Europe
  • Pfizer and BioNTech advance COVID-19 vaccine strategy with study start of next-generation vaccine candidate based on enhanced spike protein design

Research & Development

  • Scientists create long-acting injectable drug delivery system for tuberculosis
  • Treating cancer by sticking cells in place
  • Vitamin K prevents cell death: a new function for a long-known molecule
  • Disparities in United States COVID-19 vaccine distribution
  • New needle-free nasal vaccine shows promise for COVID-19
  • Scientists develop new biomimetic formulation for treating glioblastoma
  • SARS-CoV-2 hijacks nanotubes between neurons to infect them

Conferences & Events

  • New approach to treatment of deadly kidney cancer
  • SAE Media Group proudly presents the 2nd Annual Aseptic Processing Conference
  • Pharma join together to achieve new standards in digital and patient innovation for clinical transformation
  • SMi's 22nd Annual Pain Therapeutics Conference
  • SMi Group Introduces the 4th Annual Injectable Drug Delivery Conference 2022
  • SMi's 5th Annual Pharmaceutical Microbiology East Coast Conference
  • SMi's 3rd Annual AI in Drug Discovery Conference

Regulatory Affairs

  • FDA approves first systemic treatment for alopecia areata
  • FDA urges drug manufacturers to develop risk management plans to promote a dtronger, resilient drug supply chain
  • FDA limits use of Janssen COVID-19 vaccine to certain individuals
  • EMA establishes Cancer Medicines Forum with academia to optimise cancer treatments in clinical practice
  • FDA approves first generic of Symbicort to treat asthma and COPD
  1. You are here:  
  2. Home
  3. Takeda

About

  • Home
  • Advertise
  • Privacy
  • Cookie Preferences
  • Terms of Use
  • Contact

Top News Channels

  • Industry
  • Research
  • Regulatory

Submit Your News!

Follow / Join us

Didn't we got you connected? If not, please note the following magic buttons:
  • Facebook
  • Twitter
  • LinkedIn
  • XING
  • RSS

Digest World Pharma Newsletter

Subscribe to our weekly Digest Newsletter and stay updated on the latest World Pharma News. Subscribe now, it's free!

© World Pharma News 2022. All Rights Reserved.